Search

everythinglearnresearchcommunity

for

Search:↓

Seborrheic dermatitis may contribute to the development of central centrifugal cicatricial alopecia.

COVID-19 may worsen hair loss in people with a certain type of scarring alopecia, but early treatment can help improve symptoms and hair regrowth.

Accurate diagnosis is crucial for effective treatment of hair loss.

Low iron levels are linked to certain types of hair loss.

Certain genes and proteins may help diagnose and treat primary cicatricial alopecia.

Combining FUE with rb-bFGF and minoxidil is more effective and has fewer side effects than FUE alone for treating hair loss.

Hair shaft malformation contributes to Central Centrifugal Cicatricial Alopecia.

Both follicular unit extraction and scalp expanders effectively treat secondary cicatricial alopecia, with scalp expanders leading to quicker and denser hair growth.

Mutations in the PADI3 gene may cause central centrifugal cicatricial alopecia in women of African ancestry.

CCCA in women of African ancestry may be caused by PADI3 gene mutations and intense hair grooming.

Mutations in Far2 mice cause hair loss due to sebaceous gland issues.

CCCA can affect both genders and all ages, and it has a genetic component.

A woman's severe hair loss was caused by scalp psoriasis, not the initially thought condition, and treatment improved her psoriasis but couldn't restore her lost hair.

Platelet-Rich Plasma (PRP) can promote new hair growth and increase hair density, but its effectiveness varies depending on the type of hair loss.

Early shedding of the inner root sheath in noninflamed hair follicles is a relatively specific sign of Central Centrifugal Cicatricial Alopecia.

Targeting the protein Caveolin-1 might help treat a type of scarring hair loss called Frontal Fibrosing Alopecia.

Younger age, longer disease duration, frequent wig use, and lower education levels worsen quality of life in CCCA patients.

Black patients with a specific type of hair loss have a much higher chance of lacking enough vitamin D.

Early diagnosis with trichoscopy can improve management and quality of life for CCCA patients.

Mast cells may significantly contribute to central centrifugal cicatricial alopecia.

The patient with both scarring and non-scarring hair loss showed complex immune reactions and improved with steroid treatment.

Genetic factors, especially PADI3 gene variants, contribute to CCCA in women of African descent.

CCCA can appear as patchy hair loss in younger men, not just the usual pattern.

A thorough assessment and combined treatment are crucial for managing complex alopecia, especially in patients with skin of color.

Using dermoscopy improves diagnosis of scalp and hair disorders in children.

Using a special skin cream with gabapentin helped reduce symptoms of a certain scalp condition but didn't change nerve fibers or skin chemicals.

DNA analysis can help tailor alopecia treatment.

Some factors like thyroid disease, diabetes treatment, hair dryers, natural hairstyles, and scalp conditions can affect the treatment results for a hair loss condition called CCCA.

Researchers found a white halo around hair in most patients with a specific type of hair loss, which helps in early diagnosis and treatment.

Certain mouse strains develop a skin condition similar to a human hair loss disease due to genetic defects.